Octagos vs PaceMate
Octagos and PaceMate each name Epic, Oracle Health and athenahealth, so those EHRs decide nothing. Octagos also names medent and NextGen and offers a usage-based Billable Transmissions Plan next to a fixed monthly plan. Octagos names a software-only Pro tier and PaceMate a Software tier for clinics that run it themselves, neither with amounts.
A hospital security office reads the compliance pages differently. PaceMate states HITRUST r2 and ISO/IEC 27001:2022 beside SOC 2 Type 2, SOC 3 and HIPAA. Octagos states HIPAA, SOC 2 Type 2 and SOC 3 on Azure. Where policy names HITRUST, PaceMate is the buy.
Evidence runs the other way. Octagos's AI overview page describes a 2025 JACC Advances paper on 690,673 transmissions and says Atlas AI reached 99.1% sensitivity against 70.8% for technicians, though the paper is Octagos-linked. PaceMate's 73% cut in loop recorder false positives is the vendor's figure. A 2025 Heart Rhythm paper on AI algorithms for loop recorder transmissions carries a PaceMate affiliation, with use of the product unverified, and no PaceMate paper has the product in its title. For an electrophysiology director who wants a published result on the triage AI, PaceMate comes second.
Decision support · Reviewed November 2, 2026
When to pick each one
Octagos
- Medent and NextGen also named
- Usage-based Billable Transmissions Plan
- AI overview page cites a 2025 JACC Advances paper
PaceMate
- HITRUST r2 and ISO/IEC 27001:2022 stated
- Epic, Oracle Health, athenahealth bi-directional per vendor
Score
Each row shows points earned of points available under the published rubric.
Octagos
43of 100
PaceMate
47of 100
| Dimension | Octagos | PaceMate | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 10 / 10 | 0 |
| EHR integrations (count) | 2.8 / 5.6 | 1.7 / 5.6 | +1.1 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 4.8 / 4.8 | 4.8 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 14.7 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 4.5 / 9 | -4.5 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Octagos
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
PaceMate
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Octagos
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
2 PubMed records name Octagos.
PaceMate
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
3 PubMed records name PaceMate.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Octagos | PaceMate |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, Oracle Health, athenahealth, medent, NextGen | Epic, Oracle Health, athenahealth |
| Founded | n/a | n/a |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.